Ibogaine treatment for Oakland residents: the physician-prescribed pathway through Brazil

Ibogaine is a Schedule I controlled substance in the United States. No clinic, hospital, or physician in California can legally prescribe or administer it. That policy gap is not closing soon, even as Sacramento has taken steps to enable research.

In October 2025, Governor Gavin Newsom signed AB 1103 (Chapter 571), which streamlines the state Research Advisory Panel's review of federally authorized clinical studies involving Schedule I and II substances, including ibogaine. The bill took effect January 1, 2026. It enables research, not treatment. No California resident can legally receive ibogaine inside the United States as of 2026.

Alameda County's overdose toll makes the stakes visible. The county peaked at 309 drug overdose deaths in 2023 before recording 361 drug poisoning deaths in 2024 — still nearly one death per day across a county of 1.6 million people. Fentanyl-contaminated counterfeit pills and polysubstance use — fentanyl with methamphetamine, emerging threats like xylazine — drive deaths among people who have already cycled through conventional treatment.

Oakland sits at the center of the East Bay's harm-reduction infrastructure. Organizations distribute more than 50,000 doses of naloxone across Alameda County annually, and public access naloxone boxes now span 50 locations countywide. That investment saves lives. It does not reach everyone. For Oakland families who have exhausted local options — the kind of family that has already tried programs near Highland, Fruitvale, or across the Bay — the physician-prescribed pathway runs through Brazil.

If your loved one is in active addiction, you have probably heard a lot of clinical language that did not translate into results. Ibogaine is worth understanding differently, because it works differently.

Ibogaine is a naturally occurring compound derived from the root bark of the iboga plant. It acts on multiple receptor systems simultaneously, including opioid receptors, NMDA receptors, and serotonin pathways. The result, for many patients, is a dramatic reduction in acute opioid withdrawal symptoms and a reset of the neurological patterns that drive compulsive use. The full receptor-level mechanism is covered in detail on our ibogaine overview.

What makes ibogaine different from medication-assisted treatment goes beyond pharmacology. It is the window that opens after. In the weeks following a session, the brain enters a period of elevated neuroplasticity, sometimes called the Window of Wonder, that typically lasts 2 to 12 weeks. This is not a passive recovery period. It is the window that Nekawa's 15-day on-site integration and 45-day at-home coursework are specifically built around, because what a student does during that window shapes what the session becomes long-term.

Ibogaine is not appropriate for everyone. The peer-reviewed research is serious and growing, and so is the understanding of who is and is not a candidate. Cardiac history, current medications, and other health factors all matter. That is precisely why the physician-prescribed pathway requires a full medical workup before any session proceeds.

The ibogaine session at the heart of Nekawa's program is prescribed and administered by independent licensed Brazilian physicians, not by Nekawa. Understanding what that means in practice matters, because it is the difference between a supervised medical procedure and an unmonitored retreat experience.

Before the prescribing physicians clear a patient for ibogaine, the workup includes:

• EKG
• QT-interval check
• Comprehensive blood panel
• Liver function test
• Magnesium loading

The QT-interval check is the critical cardiac screen. Ibogaine affects cardiac conduction, and a prolonged QT interval is a contraindication. This is not a formality. It is the reason the medical workup exists.

During the session, an on-site physician is present throughout. The hospital's ICU-trained nursing team monitors continuous cardiac telemetry for a minimum of 24 hours post-dose. The session itself moves through distinct phases: the intense visionary phase lasts 6 to 12 hours, followed by roughly 12 hours of quieter mental processing, then 24 to 48 hours of physical recuperation.

Nekawa's role is not clinical. We build the preparation, the environment, and the integration structure around the medical team's work. The full program structure is:

• 10 days of preparation and on-site medical onboarding before the session
• The ibogaine session, administered by the medical team in a hospital setting with continuous cardiac telemetry
• 15 days of structured integration on the property
• 45 days of at-home integration coursework after returning home

Longer on-site programs of up to 90 days are available for students who want deeper transformation work. The 28-day structure is the foundation; the extended program builds on it.

See our cardiac safety overview for the full QT-interval, EKG, and screening protocol the prescribing physicians follow.

Mexico and Costa Rica have become common destinations for ibogaine, and some of the programs there are run by serious people. But the regulatory framework is not the same, and that difference matters when you are talking about a compound that requires continuous cardiac monitoring.

In Brazil, ibogaine is approved for medical use under ANVISA, Brazil's federal health agency, the equivalent of the FDA. Treatment is prescribed by licensed physicians and delivered within hospital infrastructure that includes emergency response capability. This is not a private villa. It is not a retreat center operating in a gray area. The current US and global legal status of ibogaine makes clear why the structure of the Brazilian system is distinct.

Nekawa is a wellness education academy, structured around the hospital infrastructure that physician-administered ibogaine treatment requires. We do not run the medical protocol. The prescribing physicians do. What we provide is the preparation curriculum, the environment, the integration coursework, and the program structure that gives the medical session its full context.

The distinction matters for Oakland students specifically. California passed AB 1103 to streamline ibogaine research precisely because the evidence base is credible — and Alameda County's fentanyl-driven toll is part of why that policy conversation exists. The Americans for Ibogaine state legislation tracker places California among the 18 states actively pursuing ibogaine-relevant policy. That credibility is built on the kind of physician-prescribed, hospital-administered framework Brazil has operated under for years.

Oakland International (OAK) and San Francisco International (SFO) both serve East Bay travelers heading to Brazil. Most itineraries connect through Los Angeles, Houston, or Dallas to reach São Paulo–Guarulhos (GRU) or Rio de Janeiro–Galeão (GIG). Total travel time typically runs 14 to 18 hours door to door, depending on connection length.

From either GRU or GIG, it is a 4-hour drive along the BR-101 coastal highway to Paraty, on Brazil's Costa Verde coast. We arrange private ground transport from the airport, so students arrive directly without navigating Brazilian transit or making connections.

What you arrive to is not a medical facility. Our location sits in the Atlantic rainforest, the Mata Atlântica, at the edge of the sea. Old-growth jungle. Waterfalls. A protected lagoon. A bay scattered with more than 300 forested islands. The colonial port town of Paraty is just outside. The environment is part of the program. The preparation and integration work we walk students through is designed to use the setting intentionally.

As of January 1, 2026, US travelers need an approved Brazilian eVisa to enter Brazil. Apply online at brazil.vfsevisa.com.

• Cost: US$80.90
• Processing time: about 72 hours
• Validity: 10 years, multiple entries of up to 90 days per stay
• Passport: US passport with at least 6 months of remaining validity

Our intake team walks every student through this during onboarding.

California is one of 18 US states tracked by Americans for Ibogaine as actively pursuing ibogaine-relevant policy. In October 2025, Governor Newsom signed AB 1103 (Chapter 571), which streamlines the state Research Advisory Panel's review of federally authorized clinical studies involving Schedule I and II substances, including ibogaine, psilocybin, and MDMA. The bill took effect January 1, 2026, and applies through December 31, 2027.

AB 1103 is a research-enabling bill, not a treatment bill. It makes it easier for FDA-authorized clinical trials to be conducted in California. It does not create a regulated treatment pathway, and it does not change the legal status of ibogaine for anyone seeking treatment today. California's posture is research-enabling rather than research-funding — a contrast with Texas, which established a $50 million dedicated ibogaine research fund under SB 2308 in 2025.

In April 2026, a federal Executive Order directed coordinated ibogaine research with a focus on veterans — an initiative Americans for Ibogaine covered in detail. That order accelerates federal research timelines but does not affect access to treatment in the US.

For an Oakland resident in active addiction in 2026, the practical reality is unchanged: no California provider can prescribe or administer ibogaine, and AB 1103 does not offer enrollment as a treatment option. California recorded 7,385 provisional drug overdose deaths in 2024 per CDC NCHS data — a statewide crisis that Alameda County's numbers reflect at the county level.

The ibogaine session is not the end of the program. It is closer to the beginning of the part that requires the most work.

The 45 days of at-home integration coursework that follow the on-site program are structured around the Window of Wonder, the 2 to 12 weeks of elevated neuroplasticity that follow the session. This is when the brain is most receptive to new patterns, and it is when the coursework is designed to be used. Students returning to Oakland — to a condo in Rockridge, an apartment in Temescal, or a quiet street near Lake Merritt — return to the same environment where the patterns formed. The at-home coursework is built with that reality in mind, including BART commutes, housing instability, and the social networks that make recovery in the East Bay its own challenge.

Alameda County's expanded naloxone distribution and opioid prevention programs — including MAT expansion at Santa Rita Jail — have contributed to addressing the crisis at scale. Integration is the complement on the other side of a medical session: structured reflection, specific practices, and ongoing engagement with the material from the preparation phase. Our team remains in contact with students through this period. The work continues.

For students with opioid dependence specifically, the opioid program page covers how the full curriculum is structured for that context. Students navigating burnout, depression, or anxiety alongside addiction may find the burnout and mental health program relevant as well.

The first step is a discovery call. This is a candidacy and program-fit conversation, not a sales call. We are looking at whether Nekawa's program is genuinely right for you or your loved one, and whether you are ready to do what the program requires.

On the call, we cover the program structure, the preparation curriculum, what the on-site experience involves, and what the at-home integration period looks like. We also talk honestly about who the program is not right for. Clinical screening is conducted separately by the prescribing physicians. What we assess is program fit, commitment, and readiness.

If the program is a fit, we move to intake, onboarding, and scheduling. Our intake team handles visa guidance, ground transport coordination, and preparation coursework. You do not navigate this alone.

To start, visit Book a discovery call. If you are an Oakland family member trying to understand whether this is the right path, the discovery call is the right place to begin.